Logo

American Heart Association

  84
  0


Final ID: Sa4023

Primary Percutaneous Coronary Intervention versus Thrombolytic Therapy Outside Cardiology Reference Center for Acute Myocardial Infarction: A Meta-Analysis of Randomized Control Trials

Abstract Body (Do not enter title and authors here): Introduction: Fibrinolysis is the treatment of choice for patients with ST-elevation acute myocardial infarction (STEMI) who cannot reach door-to-balloon time for primary reperfusion therapy (PCI) 1. This therapy is widely used in some countries in Europe and Brazil2. However, these patients who undergo thrombolysis have a higher mortality rate compared to patients who undergo primary PCI3. The objective of the study is to evaluate the outcomes of mortality, reinfarction and stroke in patients with STEMI who underwent thrombolysis outside referral centers (community hospitals and inside ambulances) versus patients who underwent primary PCI. Methods: We performed a systematically review and meta-analysis of randomized control trials (RTCs) comparing of pre-hospital thrombolysis (PHT) with primary coronary intervention (PCI). PubMed, Embase and Cochrane databases were searched from April 2024 with the following search terms: ‘STEMI’, ‘myocardial infarction’[Mesh],’pre hospital’,’thrombolysis’,PHT, ‘thrombolytic therapy’. We used random-effects model to estimate the Risk Ration (RR) with 95% CI. Heterogeneity was examined with I2 statistics. We also performed leave-one-out sensitivity analyses and used Review Manager 5.4 for statistical analysis. The study was registered on PROSPERO: CRD42024547309. Results: A total of 1890 patients from 3 studies RTCs were included. Pre-hospital thrombolysis was used to treat STEMI in 940 patients (49%). Follow-up time varied from 4.6 to 5 years. The average age was 60.3 years. The anterior infarction on the ECG was similar between groups: average 43% (PHT) and 41.6% (PCI). Pre-hospital thrombolysis was associated with a higher risk of reinfarction ( RR 2.33; 95% CI 1.30-4.16; p=0.004; I2=0%) and composite outcomes of stroke, mortality and reinfarction(RR 1.67; 95% CI 1.25-2.23; p=0.0005; I2=0%). No significant differences were found between treatment groups regarding mortality (RR 1.23; 95% CI 0.70-2.18; p=0.47; I2=42%) and stroke (RR 3.82; 95% CI 0.54-27.23; p=0.18; I2=38%). Conclusion: This study suggests that pre-hospital thrombolysis is associated with a higher risk of reinfarction. More randomized studies on patients treated in a pre-hospital environment are needed to better investigate this question.
  • Alves Filho, Francisco Willamy Pedrosa  ( North Regional Hospital , Sobral , Brazil )
  • Alves Lima, Nagila  ( Northern Regional Hospital , Sobral , Brazil )
  • Lopes Monte Neto, Vicente  ( Northern Regional Hospital , Sobral , Brazil )
  • Tomaz, Wellington  ( Northern Regional Hospital , Sobral , Brazil )
  • Author Disclosures:
    Francisco Willamy Pedrosa Alves Filho: DO NOT have relevant financial relationships | Nagila Alves Lima: DO NOT have relevant financial relationships | Vicente Lopes Monte Neto: No Answer | Wellington Tomaz: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

All Things STEMI

Saturday, 11/16/2024 , 02:00PM - 03:00PM

Abstract Poster Session

More abstracts on this topic:
A Fecal-Derived Commensal Bacterium BM109 Reduces Infarct Size and Neurological Deficits in an Ischemic Stroke Rat Model

Yoon Chung Eun, Kim You Bin, Nam Hyo Suk

Automated Identification of Stroke Thrombolysis Contraindications from Synthetic Clinical Notes

Chen Bing Yu, Hussain Muhammad, Gonzalez Marco, Antaki Fares, Delora Adam, Aube Eric, Albahra Samer, Robertson Scott, Uchino Ken, Russman Andrew

You have to be authorized to contact abstract author. Please, Login
Not Available